Report of Foreign Issuer (6-k)
July 08 2019 - 7:23AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE
13a-16
OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of July 2019
Commission File Number:
001-37452
CELYAD SA
(Translation
of registrants name into English)
Rue Edouard
Belin 2
1435 Mont-Saint-Guibert, Belgium
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form
20-F
or Form
40-F.
Form
20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101(b)(7): ☐
Celyad SA
On July 5
th
, 2019, Celyad SA (the
Company
) issued a press release, a copy of which is
attached hereto as Exhibit 99.1 and is incorporated by reference herein.
The information contained in this Current Report on
Form 6-K, including
Exhibit 99.1, except for the quote of Filippo Petti and Eric Van Cutsem contained in Exhibit 99.1, is hereby incorporated by reference into the Companys Registration Statements on
Forms F-3 (File No. 333-220285)
and S-8 (File No. 333-220737).
EXHIBITS
|
|
|
Exhibit
|
|
Description
|
|
|
99.1
|
|
Press release issued by the registrant on July 5, 2019
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
CELYAD SA
|
|
|
|
|
Date: July 8
th
, 2019
|
|
|
|
By:
|
|
/s/ Filippo Petti
|
|
|
|
|
|
|
Filippo Petti
|
|
|
|
|
|
|
Chief Executive Officer
|
Celyad Oncology (NASDAQ:CYAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celyad Oncology (NASDAQ:CYAD)
Historical Stock Chart
From Apr 2023 to Apr 2024